New biomarkers for early detection of cardiotoxicity after treatment with docetaxel, doxorubicin and cyclophosphamide

Cancer Treatment–Related Cardiotoxicity: Current State of Knowledge and Future Research Priorities

(2014) Nonniekaye Shelburne et al.   JNCI-Journal of the National Cancer Institute

Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab

(2012) Heloisa Sawaya et al.   Circulation-Cardiovascular Imaging

Multiple Biomarkers for Risk Prediction in Chronic Heart Failure

(2012) Bonnie Ky et al.   Circulation-Heart Failure

Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients

(2011) S Romano et al.   BRITISH JOURNAL OF CANCER

Usefulness of Myeloperoxidase Levels in Healthy Elderly Subjects to Predict Risk of Developing Heart Failure

(2009) W.H. Wilson Tang et al.   AMERICAN JOURNAL OF CARDIOLOGY

Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: Effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide

(2009) Mauro Feola et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines

(2009) Annelies M.C. Mavinkurve-Groothuis et al.   PEDIATRIC BLOOD & CANCER

Reference intervals for circulating angiogenic cytokines

(2008) Sun-Young Kong et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults

(2008) Fotiní Dodos et al.   Clinical Research in Cardiology

Biomarkers in Heart Failure

(2008) Eugene Braunwald   NEW ENGLAND JOURNAL OF MEDICINE

Persistence, Up to 18 Months of Follow-Up, of Epirubicin-Induced Myocardial Dysfunction Detected Early by Serial Tissue Doppler Echocardiography: Correlation with Inflammatory and Oxidative Stress Markers

(2008) G. Mantovani et al.   ONCOLOGIST